Aquestive Therapeutics, Inc. AQST
Set alert
At close
Pre-market · Nov 3, 7:35 AM ET
- YTD
- -41.64%
- 1 year
- -41.91%
- Open
- 3.92
- Prev close
- 3.89
- Mkt cap
- 473.18M
- Vol
- 2.63M
- Avg vol
- 2.74M
- EPS
- -0.66
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.64
- High
- 3.96
- Forward P/E
- -5.87
- Beta
- 2.82
- Short ratio
- 6.37
- Inst. own
- 55.98%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 4.68
- 200-d avg
- 4.02
- 1y target
- 10.83
5D chart
Signals (56)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 16 hours ago |
| RSI: Overbought | Nov 2, 3:10 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 2:40 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 2:25 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 12:25 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 12:15 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 12:10 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 12:10 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 12:05 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 12:00 PM | 19 hours ago |
| RSI: Oversold | Nov 2, 11:40 AM | 20 hours ago |
| RSI: Oversold | Nov 2, 10:35 AM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 10:05 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:50 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 9:50 AM | 22 hours ago |
| SMA: Bullish | Nov 2, 9:45 AM | 22 hours ago |
Newest 20 of 56.
News
1 week ago globenewswire.com
Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET
WARREN, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to bring meaningful…
-
2 weeks ago benzinga.com
FDA Accepts Aquestive Therapeutics’ Anaphylm NDA Resubmission; PDUFA Goal Action Date Set For March 16, 2027
FDA accepted the resubmission as complete and classified it as a Class 2 responsePrescription Drug User Fee Act (PDUFA) goal action date set for March 16, 2027Ex-U.S. strategy remains on track with…
2 weeks ago benzinga.com
Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug
Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.
-
2 weeks ago benzinga.com
Eton Pharmaceuticals And Aquestive Therapeutics Enter Exclusive U.S. License And Supply Agreement For LIBERVANT Buccal Film For Seizure Clusters In Patients With Epilepsy; Sees Commercial Availability In April 2027
Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually…
1 month ago benzinga.com
Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment
Aquestive Therapeutics has resubmitted its New Drug Application to the FDA for Anaphylm, a sublingual film for severe allergic reactions.
-
2 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains $10 price target.
-
2 months ago benzinga.com
Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $50.584M Est
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $50.584 million estimate.
2 months ago benzinga.com
Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study
Aquestive Therapeutics reports positive study results for Anaphylm sublingual film, paving the way for a Q3 FDA resubmission.
2 months ago benzinga.com
Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday
BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained 16.4%, AQST gained 15.4%, STDN rose 13.7%.
5 months ago benzinga.com
Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday
U.S. stocks rose, with Dow Jones up 300 points. STAA shares surged after better-than-expected results. Other big gainers include POET, STUB, MSC, ARX, CSCO, PCT, WOLF, CPA, ONDS, KLAR, and RDW.
5 months ago benzinga.com
Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript
Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript
5 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
5 months ago benzinga.com
Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $48.072M Est
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $48.072 million estimate.
-
5 months ago benzinga.com
Aquestive Therapeutics Q1 EPS $(0.07) Beats $(0.15) Estimate, Sales $14.446M Beat $10.896M Estimate
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 70.83 percent increase over losses…
-
7 months ago benzinga.com
Aquestive Therapeutics Completes In-Person Type A Meeting With FDA Regarding Resubmission Of NDA For Anaphylm Sublingual Film For Treatment Of Type 1 Allergic Reactions, Including Anaphylaxis
Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science…
8 months ago benzinga.com
Aquestive Therapeutics Q4 Earnings Assessment
Aquestive Therapeutics Q4 Earnings Assessment
-
8 months ago benzinga.com
Aquestive Therapeutics Sees FY2026 Sales $46.000M-$50.000M vs $49.888M Est
Aquestive Therapeutics (NASDAQ:AQST) sees FY2026 sales of $46.000 million-$50.000 million vs $49.888 million analyst estimate.
-
8 months ago benzinga.com
Aquestive Therapeutics Q4 Adj. EPS $(0.15) Misses $(0.13) Estimate, Sales $13.015M Miss $13.284M Estimate
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 12.78 percent. This is a 21.05 percent increase over…
-
8 months ago benzinga.com
A Preview Of Aquestive Therapeutics's Earnings
A Preview Of Aquestive Therapeutics's Earnings
9 months ago benzinga.com
What Does the Market Think About Aquestive Therapeutics Inc?
What Does the Market Think About Aquestive Therapeutics Inc?
9 months ago benzinga.com
What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?
Aquestive received an FDA rejection for its allergy film due to safety and use issues. The company plans new studies and targets resubmission in 2026.
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
9 months ago benzinga.com
Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday
Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday
-
9 months ago benzinga.com
Aquestive Therapeutics Receives CRL From FDA For NDA Seeking Approval Of Anaphylm Sublingual Film For Treatment Of Type I Allergic Reactions, Including Anaphylaxis, In Patients Weighing 30kg Or More
Deficiencies limited to packaging and administration Company believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026 Remains well-capitalized and anticipates ending…
-
9 months ago benzinga.com
Peering Into Aquestive Therapeutics Inc's Recent Short Interest
Peering Into Aquestive Therapeutics Inc's Recent Short Interest
9 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
9 months ago benzinga.com
Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
9 months ago benzinga.com
Bad News For Competitor Turns Into Big Win For ARS Pharma Stock
ARS Pharmaceuticals Inc. stock rose Friday as FDA identified deficiencies in rival Aquestive's application, delaying potential competition.
9 months ago benzinga.com
Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January
Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
9 months ago benzinga.com
Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application
Aquestive Therapeutics shares fall after the FDA flags deficiencies in its Anaphylm allergy drug application, raising approval delay concerns despite the review remaining active.
9 months ago benzinga.com
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
-
9 months ago benzinga.com
Aquestive Therapeutics Updates Anaphylm Regulatory Status Following FDA Letter While Advancing International Approval Efforts
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA…
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
9 months ago benzinga.com
Aquestive Therapeutics Receives FDA Letter Identifying Deficiencies That Preclude Labeling Discussions For Anaphylm (Dibutepinephrine) Sublingual Film
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA…
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
1 year ago benzinga.com
Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
1 year ago benzinga.com
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
1 year ago benzinga.com
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
1 year ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
-
1 year ago benzinga.com
Earnings Scheduled For August 11, 2025
Earnings Scheduled For August 11, 2025
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
2 years ago benzinga.com
Dow Surges 350 Points; Fed Holds Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also…